Balance Sheet
Cash Flow Statement
Daily Values
DMA 100DMA 200DMA 50Dividend YieldEV to CFOEV to EBITEV to EBITDAEV to FCFEV to RevenueEnterprise ValueMarket Cap to FCFMarket CapitalizationPricePrice to EarningsPrice to Sales
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

GoHealth (GOCO) Enterprise Value (2020 - 2025)

GoHealth (GOCO) has disclosed Enterprise Value for 6 consecutive years, with -$133.0 million as the latest value for Q4 2025.

  • Quarterly Enterprise Value fell 208.4% to -$133.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$133.0 million through Dec 2025, down 208.4% year-over-year, with the annual reading at -$133.0 million for FY2025, 208.4% down from the prior year.
  • Enterprise Value hit -$133.0 million in Q4 2025 for GoHealth, down from -$107.2 million in the prior quarter.
  • In the past five years, Enterprise Value ranged from a high of $782.1 million in Q2 2021 to a low of -$133.0 million in Q4 2025.
  • Historically, Enterprise Value has averaged $242.3 million across 5 years, with a median of $149.6 million in 2022.
  • Biggest five-year swings in Enterprise Value: skyrocketed 760.9% in 2021 and later plummeted 209.69% in 2025.
  • Year by year, Enterprise Value stood at $455.0 million in 2021, then plummeted by 43.48% to $257.2 million in 2022, then crashed by 67.4% to $83.8 million in 2023, then skyrocketed by 46.34% to $122.7 million in 2024, then plummeted by 208.4% to -$133.0 million in 2025.
  • Business Quant data shows Enterprise Value for GOCO at -$133.0 million in Q4 2025, -$107.2 million in Q3 2025, and $51.7 million in Q2 2025.